Valuation: IRIDEX Corporation

Market Cap 19.76M 17.3M 15.97M 14.91M 28.07M 1.87B 28.71M 192M 74.19M 921M 74.19M 72.57M 3.2B P/E 2026 *
-22.7x
P/E 2027 * 56.8x
Enterprise Value 19.76M 17.3M 15.97M 14.91M 28.07M 1.87B 28.71M 192M 74.19M 921M 74.19M 72.57M 3.2B EV / Sales 2026 *
0.37x
EV / Sales 2027 * 0.35x
Free-Float
68.77%
Yield 2026 *
-
Yield 2027 * -
1 day+0.44%
1 week-3.81%
Current month+8.10%
1 month+8.10%
3 months+14.65%
6 months-2.99%
Current year-0.44%
1 week 1.12
Extreme 1.12
1.2
1 month 1.04
Extreme 1.045
1.2
Current year 0.95
Extreme 0.9496
1.65
1 year 0.87
Extreme 0.8688
1.65
3 years 0.78
Extreme 0.782
3.65
5 years 0.78
Extreme 0.782
9.46
10 years 0.78
Extreme 0.782
16.64
Manager TitleAgeSince
Chief Executive Officer 54 2024-09-30
Director of Finance/CFO 68 2018-12-17
Investor Relations Contact - -
Director TitleAgeSince
Chairman 60 2020-06-23
Director/Board Member 54 2018-08-31
Director/Board Member 66 2022-03-16
Date Insider Type Main position Quantity % Market Cap.
Jun. 12Tax

Chief Executive Officer

-3,990 0.0229%
Jun. 12Tax

Chief Financial Officer

-2,691 0.0155%
Jun. 11Buy

Chief Financial Officer

975 0.0056%
Change 5-day change 1-year change 3-year change Capi.($)
+0.44%-3.81%+28.98%-47.70% 19.76M
-1.38%+6.85%+23.69%-3.88% 188B
-1.54%-0.46%-26.15%+17.37% 144B
-0.99%+7.35%-2.74%-19.95% 136B
-1.55%-5.15%-59.73%-20.04% 64.63B
-1.33%+4.09%+15.73%-4.05% 52.5B
-0.13%-1.13%-27.48%-34.19% 43.4B
-1.10%+3.77%+11.39%+9.31% 37.52B
+0.08%+3.03%+5.44%+38.07% 36.22B
-2.13%+0.86%-13.24%-20.89% 29.59B
Average -0.98%+3.64%-4.41%-8.59% 73.23B
Weighted average by Cap. -1.21%+5.68%-5.01%-3.87%

Financials

2026 *2027 *
Net sales 53M 46.41M 42.84M 40.01M 75.31M 5.01B 77.02M 516M 199M 2.47B 199M 195M 8.58B 56.77M 49.7M 45.89M 42.85M 80.66M 5.37B 82.5M 552M 213M 2.65B 213M 209M 9.19B
Net income -795K -696K -643K -600K -1.13M -75.16M -1.16M -7.73M -2.99M -37.08M -2.99M -2.92M -129M 361K 316K 292K 272K 513K 34.13M 525K 3.51M 1.36M 16.84M 1.36M 1.33M 58.46M
Net Debt - -
Logo IRIDEX Corporation
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Employees
93
Date Price Change Volume
26-06-30 $1.130 -0.44% 1,789
26-06-29 $1.135 +0.44% 57,032
26-06-26 $1.130 -4.24% 29,320
26-06-25 $1.180 -0.84% 42,752
26-06-24 $1.190 +0.85% 22,719
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.135USD
Average target price
2.750USD
Spread / Average Target
+142.29%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRIX Stock